Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s (Q35193326)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s
scientific article

    Statements

    Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s (English)
    Douglas Kitch
    Camlin Tierney
    Nasreen C Jahed
    Laurie Myers
    Kathleen Melbourne

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit